Abstract
We thank the authors for their interest in our meta-analysis on diagnostic and prognostic models for clinical high risk (CHR) individuals (1). Raballo et al. (2) discuss the critical issue of antipsychotics (APs) within the CHR paradigm and its potential role in predictive models for detection of transition to psychosis. Specifically, Raballo et al. highlighted three points: 1) the majority of predictive models lack information about APs in high-risk cohorts, 2) baseline APs could influence the clinical presentation of individuals and/or modify the longitudinal development of their symptoms, and 3) the presence of APs at baseline in CHR individuals might signal higher psychopathological severity and thus be a proxy for higher risk of developing psychosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
